|
Post by account_disabled on Jan 1, 2024 6:47:51 GMT 1
Bangkok, September 25, 2019 - “BGIC” is the leader in biotechnology business development in Thailand. Join hands in joint venture with "Genexine", a giant biotechnology company from South Korea. Ready to join forces with experts in every sector, both domestic and international. Entering the modern pharmaceutical industry Moving forward with the development of biopharmaceuticals In line with the world market growing at twice as high. Aiming to raise the level of C Level Executive List the Thai biopharmaceutical industry to the world level and become the number one research and development center and drug production base in ASEAN. Mr. Marut Buranasetthakul Chief Executive Officer of Bio Genetech International Company Limited (BGIC), a leader in biotechnology business development. (Biotechnology) about biopharmaceuticals (Biopharmaceutical) 1 and others revealed that BGIC sees opportunities and benefits that will arise in the pharmaceutical production industry using biotechnology in Thailand. which will lead the country into a new era of economy Therefore, a memorandum of understanding has been made with various leading educational institutions. Both inside and abroad To cooperate and support research and development Biopharmaceutical products Ready to push to become a rising star industry of the country Including preparing to develop the potential of "BGIC" to be a center facilitating the provision of various biotechnology services, whether it be research management services and research patents (License–in & License-out Management). Companies create and/or improve structures.
|
|